Multiple sclerosis (MS) is the most prevalent neurodegenerative disease among young adults, affecting more than 2.3 million people worldwide. It is characterized by T‑cell–mediated attacks on oligodendrocytes that destroy myelin in the central nervous system. Myelin is restored through a highly efficient regenerative process orchestrated by oligodendrocyte progenitor cells (OPCs). However, the accumulation of repeated inflammatory insults leads to chronic inflammation and impaired remyelination, ultimately resulting in neurodegeneration.
Despite advances in MS treatments, we are still unable to block chronic inflammation or enhance myelin regeneration, and therefore cannot prevent motor and cognitive decline. Consequently, research aimed at limiting chronic inflammation and boosting remyelination is urgently needed.
The main objective of this project is to investigate the emerging concept of trained immunity in stem cells and to determine whether OPCs, as stem‑like cells, are susceptible to developing inflammatory memory that alters their response to subsequent inflammatory insults and contributes to MS progression. Recent studies have shown that certain stem cells can acquire trained immunity through epigenetic reprogramming, thereby modulating their response to later stimuli. Our preliminary data indicate that OPCs modify their secretome, cytokine production, and their ability to differentiate into oligodendrocytes when exposed to consecutive inflammatory stimuli.
Moreover, similar to what has been observed in other stem cell populations, we have found that following demyelination, OPCs express transcription factors associated with the maintenance of epigenetic reprogramming underlying inflammatory memory, and that this expression persists over time—even after the regenerative process has concluded.
Therefore, this project aims to determine whether OPCs are susceptible to developing trained immunity and whether prior inflammatory events alter OPC responses to subsequent insults through epigenetic reprogramming. To address this, we will carry out the following tasks:
1) Investigate whether inflammatory processes that mimic infections alter OPC biology in the short and long term.
2) Determine whether these inflammatory events modulate the subsequent response of OPCs to inflammatory and pro‑differentiation stimuli.
3) Examine whether OPCs undergo long‑lasting epigenetic reprogramming in response to inflammatory processes.
4) Assess whether inflammatory events alter OPC responses to demyelinating insults, thereby contributing to MS development.
Understanding whether OPCs acquire inflammatory memory through trained immunity—and how such memory affects their ability to control inflammation and orchestrate remyelination—is essential for elucidating the link between infections and susceptibility to MS, as well as the role of OPC inflammatory memory in disease development. We expect that the knowledge generated in this project will help establish the foundation for investigating the molecular mechanisms underlying trained immunity in OPCs. In the future, this could enable the development of new therapeutic targets by modulating OPC inflammatory memory, thereby enhancing remyelination, limiting inflammation, and ultimately halting MS progression.


